Cartesian Therapeutics, Inc. Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted
Cartesian Therapeutics, Inc. (RNAC) reported Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted of $2.05 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Earnings Per Share
us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted · last filed 2026-08-06
- Cartesian Therapeutics, Inc. undistributed earnings (loss) allocated to participating securities, diluted for the quarter ending 2026-06-30 was $2.05M, a 22.03% decline year-over-year.
- Cartesian Therapeutics, Inc. undistributed earnings (loss) allocated to participating securities, diluted for the quarter ending 2025-06-30 was $2.63M, a 37.55% decline year-over-year.
- Cartesian Therapeutics, Inc. undistributed earnings (loss) allocated to participating securities, diluted for the quarter ending 2024-06-30 was $4.21M.
- Cartesian Therapeutics, Inc. undistributed earnings (loss) allocated to participating securities, diluted for the quarter ending 2023-06-30 was $0.00.
| Period end | Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted 3 month | Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted 6 month |
|---|---|---|
| 2026-06-30 | $2.05M 10-Q · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 |
| 2025-06-30 | $2.63M 10-Q · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 |
| 2024-06-30 | $4.21M 10-Q · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |